Analyst upgrades:

• Jefferies upgraded Biogen (NASDAQ: BIIB) to Buy from Hold based on valuation. The firm, which has a $50 target on the stock, believes Tysabri PML cases are reflected in shares.
• Deutsche Bank upgraded Nordstrom (NYSE: JWN) to Buy from Hold as it finds the valuation attractive and believes the company's sales are benefiting from stabilization in California and share gains. Deutsche raised its target on shares to $45 from $36.
• RBC Capital upgraded Yum! Brands (NYSE: YUM) to Outperform from Sector Perform and raised its target to $39 from $36 citing valuation and views it as a low risk option on a global economic recovery.
• Credit Suisse (NYSE: CS) was upgraded to Buy from Hold at Citigroup.
• Royal Caribbean (NYSE: RCL) was upgraded to Outperform from Market Perform at Wells Fargo.
• Alcatel-Lucent (NYSE: ALU) was upgraded to Hold from Sell at RBS.

Here are some highlights from last week's earnings coverage from BloggingStocks:

• AirTran Holdings Inc. (NYSE: AAI) reported its third consecutive quarterly profit and will increase capacity.
• Amazon.com Inc. (NASDAQ: AMZN) shares soared after it reported very strong Q3 numbers.
• Apple Inc. (NASDAQ: AAPL) reported stellar Q4 results, driven by the popularity of Macs and iPhones.
• BlackRock Inc. (NYSE: BLK) Q3 earnings soared, due in part to a tax benefit, and assets managed grew.
• Broadcom Corp. (NASDAQ: BRCM) revenue surged sequentially but note the would be flat going forward.
• Caterpillar Inc. (NYSE: CAT) beat Q3 earnings expectations and shares rose though revenue slumped.

While the federal government plans to spend more on healthcare, the fact remains that the sector will continue to remain under cost pressures. It certainly doesn't help that the US economy continues to be mired in an economic morass.

But, Accretive Health has a solution: a system to manage revenue cycles for healthcare providers. In fact, because of the momentum of its business, the company plans to launch an IPO.

Deutsche Bank (NYSE: DB) closed at $64.23. DB September option implied volatility is at 49, October is at 51; below its 26-week average of 66, according to Track Data, suggesting decreasing price movement.

Credit Suisse (NYSE: CS) closed at $47.94. CS October option implied volatility of 47 is below its 26-week average of 62 according to Track Data, suggesting decreasing price movement.

UBS AG (NYSE: UBS), Switzerland's biggest bank, closed at $17.02. UBS September option implied volatility is at 54, October is at 56; below its 26-week average of 70, according to Track Data, suggesting decreasing price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Banking crisis? Well, banks continue to post profits. Look at Barclays PLC (NYSE: BCS), which today reported a $3.15 billion profit for the first half of 2009.

Why the growth? Interestingly enough, Barclays got a big boost from its investment banking division (which is focused on mergers & acquisitions, public offerings and capital raises). Keep in mind that the company purchased the U.S. operations of Lehman Brothers.

And the strength is no fluke. Other major banks -- such as Goldman Sachs (NYSE: GS), Credit Suisse (NYSE: CS) and JPMorgan Chase (NYSE: JPM) -- also posted strong results with investment banking.

Analyst upgrades:

• Jefferies upgraded Autodesk (NASDAQ: ADSK) to Buy from Hold after the firm's channel checks indicated the company's business is stabilizing. Jefferies raised its target on shares to $27 from $20.
• Citigroup upgraded Veeco (NASDAQ: VECO) to Buy from Hold on expectations LED order momentum will continue and cost discipline will help margin leverage. Citi raised its target on shares to $24 from $8.
• Deutsche Bank upgraded Domtar (NYSE: UFS) to Buy from Hold on expectations earnings will improve meaningfully over the next year. The firm keeps a $24 price target on the stock.
• Varian (NASDAQ: VARI) was upgraded to Equal Weight from Underweight at Barclays.
• Air Products (NYSE: APD) was upgraded to Overweight from Neutral at JPMorgan.
• U.S. Steel (NYSE: X) was upgraded to Buy from Neutral at Goldman.

Analyst upgrades:

• Citigroup upgraded Robert Half (NYSE: RHI) to Hold from Sell following the company's Q2 results, believing the worst may be behind the company. Citi raised its target on shares to $24 from $18.
• Goldman upgraded AnnTaylor (NYSE: ANN) to Buy from Neutral and raised its target to $13 from $6.50, citing improved merchandising and inventories.
• Baird upgraded TrueBlue (NYSE: TBI) to Outperform from Underperform and raised its target to $12 from $9, citing the better-than-expected Q2 report and guidance, strong balance sheet, and valuation.
• F5 Networks (NASDAQ: FFIV) was upgraded to Neutral from Underperform at BofA/Merrill.
• Credit Suisse (NYSE: CS) was upgraded to Buy from Hold at Deutsche Bank.
• Sanmina (NASDAQ: SANM) was upgraded to Neutral from Underperform at Credit Suisse.

The complicated legal fight over the implosion of the private equity buyout of Huntsman (NYSE: HUN) has been settled. The firm was able to get $632 million in cash and $1.1 billion in financing from Credit Suisse (NYSE: CS) and Deutsche Bank (NYSE: DB).

Basically, Huntsman claimed that these financial firms failed to uphold their responsibilities in backing the takeover from Hexion Specialty Chemicals, which was struck in July 2007 at $28 per share. Now, Huntsman is trading at $5.92, primarily because of the plunge in the global chemicals sector.

TheStreet.com's Jim Cramer says the government's sweeping plan to regulate compensation will cripple the public banks.

You should quit and go to work at a small hedge fund or private broker.
There. That's the memo you should be receiving right now if you work at Goldman Sachs (NYSE: GS) (Cramer's Take) or Morgan Stanley (NYSE: MS) (Cramer's Take) or JPMorgan (NYSE: JPM) (Cramer's Take) (in private banking) or Credit Suisse (NYSE: CS) (Cramer's Take) or anyone else that is pubic. The days of the "bonus" are over if you are at a public firm. The days when you did well and they sat down and figured your cut are gone. The American people, led by President Obama, won't stand for it.

I don't know how else to read the extension of the pay scrutiny from TARP banks to non-TARP banks. It just isn't going to be worth it unless you aren't in the public space. The bonus era is over.

Analyst upgrades:

• Citigroup upgraded Research in Motion (NASDAQ: RIMM) to Buy from Hold and added the stock to its Top Picks Live List. The firm believes RIMM's outlook is more secure given its unit growth trajectory and stabilizing margins. Citi raised its target on the stock to $100 from $65.
  
• Morgan Stanley upgraded Microsoft (NASDAQ: MSFT) to Overweight from Equal Weight following the company's Q3 results it believes growth is accelerating and expectations are low. The firm raised its target on the stock to $24 from $21.
  
• Deutsche Bank upgraded Huron (NYSE: HURN) to Buy from Hold as it believes bad news is already priced in and FY09 expectations are achievable. The firm keeps a $46 target on the stock.
• Credit Suisse (NYSE: CS) was upgraded to Neutral from Sell at UBS.
  
• Quicksilver (NYSE: KWK) was raised to Buy from Neutral at Banc of America/Merrill.
  
• EIG Resources (NYSE: EOG) was lifted at Goldman to Conviction Buy from Neutral.

Analyst upgrades:

• Friedman Billings upgraded LSI Corp (NYSE: LSI) to Outperform from Market Perform as it believes the risk/reward is attractive at current levels as the company's near-term business trends are stabilizing. The firm maintains a $4 target on the stock.
  
• Merriman upgraded shares of Medarex (NASDAQ: MEDX) to Neutral from Sell on valuation following the stock's 40% decline year-to-date.
  
• Morgan Stanley upgraded ITT Educational (NYSE: ESI) to Overweight from Equal Weight. The firm believes valuation appropriately discounts risks from its internal lending program.
• Noble (NYSE: NE) was upgraded to Buy from Neutral at Goldman and added to the Conviction Buy List.
  
• Energizer (NYSE: ENR) was raised to Neutral from Sell at UBS.
  
• Arch Chemicals (NYSE: ARJ) was upgraded at KeyBanc to Hold from Underweight.

Analyst upgrades:

• Baird upgraded Starwood Hotels (NYSE: HOT), Host Hotels (NYSE: HST) and Marriott (NYSE: MAR) to Outperform from Neutral based on valuation and indications that negative sentiment has reached a bottom.
• Citigroup upgraded Torchmark (NYSE: TMK) to Buy from Hold as they find the valuation attractive and think management can grow earnings and book value in 2009/2010. Despite upgrading, the firm lowered their target price to $37 from $45.
• ASM International (NASDAQ: ASMI) was added to Goldman's Conviction Buy List.
• Credit Suisse (NYSE: CS) was raised to Overweight from Equal Weight at Morgan Stanley.
• Live Nation (NYSE: LYV) was upgraded at Natixis to Buy from Hold.

Before the bell: Stocks to rebound, but investors remain cautious

ArcelorMittal (NYSE: MT) swung to a surprising $2.6 billion loss in the fourth quarter -- its first ever -- as it experienced a collapse in demand and a sharp drop in prices. It wrote down $4.4 billion in pre-tax charges. The steel giant is also shedding some 9,000 workers. MT shares jumped over 6% in premarket trade.

Applied Materials (NASDAQ: AMAT) warned late Tuesday that chipmakers will spend 50% less this year for its products. The maker of semiconductor production equipment also posted a fiscal first-quarter loss of $3 million, excluding charges, and said it will cut 14% of its workforce, or about 2,000 jobs, as well as production. AMAT shares declined some 2% in premarket trade.

Analyst upgrades:

• Jefferies upgraded MSC Industrial (NYSE:MSM) to Buy from Hold after meeting with management as they believe shares are attractive at current levels. The firm raised their target price to $44 from $32.
  
• UBS upgraded DuPont Fabros (NYSE:DFT) to Buy from Neutral and raised their target to $7 from $2. The firm believes DuPont Fabros will receive a waiver on its CH1 Construction loan for at least a year.
  
• Royal Bank of Scotland upgraded Credit Suisse (NYSE:CS) to Buy from Hold to reflect the company's derisking of its trading book.
• Smith & Nephew (NYSE:SNN) was upgraded to Buy from Neutral at Goldman and added to the Conviction Buy List; Cigna (NYSE:CI) was also added to the Conviction Buy List.
  
• Affymetrix (NASDAQ:AFFX) was raised to Equal Weight from Underweight at Morgan Stanley.
  
• Airtran Holdings (NYSE:AAI) was upgraded to Buy from Hold at Jesup & Lamont.

Deutsche Bank (NYSE: DB) warned of a loss of about 4.8 billion euros in Q4. DB is recently trading at $28.36 in pre-open trading, below its close of at $31.90. DB January option implied volatility of 91 is above its 26-week average of 71, according to Track Data, suggesting larger price movement.

Credit Suisse (NYSE: CS) closed at $25.20. CS option implied volatility of 87 is above its 26-week average of 72 according to Track Data, suggesting larger price movement.

UBS AG (NYSE: UBS), Switzerland's biggest bank, closed at $13.43. UBS February option implied volatility of 81 is near its 26-week average of 78, according to Track Data, suggesting non-directional price movement.

Banco Santander (NYSE: STD) closed at $8.67. STD was cut to Sell from Neutral at UBS Warburg. STD overall option implied volatility of 63 is near its 26-week average according to Track Data, suggesting non-directional price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com